Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 10

1.

Biomarker testing for breast, lung, and gastroesophageal cancers at NCI designated cancer centers.

Schink JC, Trosman JR, Weldon CB, Siziopikou KP, Tsongalis GJ, Rademaker AW, Patel JD, Benson AB 3rd, Perez EA, Gradishar WJ.

J Natl Cancer Inst. 2014 Sep 12;106(10). pii: dju256. doi: 10.1093/jnci/dju256.

2.

Deciphering next-generation pharmacogenomics: an information technology perspective.

Potamias G, Lakiotaki K, Katsila T, Lee MT, Topouzis S, Cooper DN, Patrinos GP.

Open Biol. 2014 Jul;4(7). pii: 140071. doi: 10.1098/rsob.140071.

3.

Applications of CYP450 testing in the clinical setting.

Samer CF, Lorenzini KI, Rollason V, Daali Y, Desmeules JA.

Mol Diagn Ther. 2013 Jun;17(3):165-84. doi: 10.1007/s40291-013-0028-5. Review.

4.

Leveraging epidemiology and clinical studies of cancer outcomes: recommendations and opportunities for translational research.

Elena JW, Travis LB, Simonds NI, Ambrosone CB, Ballard-Barbash R, Bhatia S, Cerhan JR, Hartge P, Heist RS, Kushi LH, Lash TL, Morton LM, Onel K, Pierce JP, Robison LL, Rowland JH, Schrag D, Sellers TA, Seminara D, Shu XO, Thomas NE, Ulrich CM, Freedman AN.

J Natl Cancer Inst. 2013 Jan 16;105(2):85-94. doi: 10.1093/jnci/djs473. Review.

5.

Comparative effectiveness research, genomics-enabled personalized medicine, and rapid learning health care: a common bond.

Ginsburg GS, Kuderer NM.

J Clin Oncol. 2012 Dec 1;30(34):4233-42. doi: 10.1200/JCO.2012.42.6114. Review.

6.

Personalized medicine - where do we stand? Pouring some water into wine: a realistic perspective.

Gundert-Remy U, Dimovski A, Gajović S.

Croat Med J. 2012 Aug;53(4):314-20.

7.

Variants downstream of the ornithine decarboxylase gene influence risk of colorectal adenoma and aspirin chemoprevention.

Barry EL, Mott LA, Sandler RS, Ahnen DJ, Baron JA.

Cancer Prev Res (Phila). 2011 Dec;4(12):2072-82. doi: 10.1158/1940-6207.CAPR-11-0300.

8.
9.

Population sciences, translational research, and the opportunities and challenges for genomics to reduce the burden of cancer in the 21st century.

Khoury MJ, Clauser SB, Freedman AN, Gillanders EM, Glasgow RE, Klein WM, Schully SD.

Cancer Epidemiol Biomarkers Prev. 2011 Oct;20(10):2105-14. doi: 10.1158/1055-9965.EPI-11-0481. Review.

10.

A pharmacogenomic method for individualized prediction of drug sensitivity.

Cohen AL, Soldi R, Zhang H, Gustafson AM, Wilcox R, Welm BE, Chang JT, Johnson E, Spira A, Jeffrey SS, Bild AH.

Mol Syst Biol. 2011 Jul 19;7:513. doi: 10.1038/msb.2011.47.

Items per page

Supplemental Content

Support Center